Skip to main content

MoneyWorks4Me

Lupin informs about press release

03 Apr 2019 Evaluate

Lupin has informed about submission of a Press Release as regards receipt of successful completion of the US FDA inspection at the Company's Lupin Bioresearch Centre without any observations. This is a disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1763.10
Dr. Reddys Labs. 1342.30
Cipla 1361.20
Lupin 1991.50
Zydus Lifesciences 1182.25
View more..